Article
HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma
12 Feb 2019
Abstract excerpt
Malignant mesothelioma (MM) is a rare, aggressive, and highly lethal cancer that is substantially induced by exposure to asbestos fibers. High-mobility group box 1 (HMGB1) is an intriguing proinflammatory molecule involved in MM. In this review, we describe the possible crucial roles of HMGB1 in carcinogenic mechanisms based on in vivo and in vitro experimental evidence and outline the clinical findings of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
